Mark Lappe
Chief Executive Officer, Director at Inhibrx Biosciences, Inc. (INBX)
Mark Lappe has filed 14 insider reports with the SEC since January 2021, as chief Executive Officer and director at Inhibrx Biosciences, Inc. (INBX). In the last 12 months Mark Lappe bought $3.64M of stock on the open market. In the latest filing, on September 28, 2026, Mark Lappe bought 10,000 shares of Inhibrx Biosciences, Inc. (INBX) for $999K at an average of $99.88.
- Filings
- 14
- Companies
- 1
- Bought on market
- $6.06M
- Sold on market
- $2.82M
Companies where Mark Lappe is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Director | $6.06M | $2.82M | $30.45 | $74.18+144% | Sep 28, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 28, 2026+$999KINBXChief Executive Officer Lappe Mark bought $998,784 worth of shares (10,000 units at $99.88)Form 4Open-market purchase
- Sep 8, 2026+$2.65MINBXChief Executive Officer Lappe Mark bought $2,645,399 worth of shares (25,000 units at $105.82)Form 4Open-market purchase
- Sep 16, 2024+$629KINBXChief Executive Officer Lappe Mark bought $629,117 worth of shares (40,000 units at $15.73)Form 4Open-market purchase
- Sep 10, 2024+$671KINBXChief Executive Officer Lappe Mark bought $671,150 worth of shares (44,000 units at $15.25)Form 4Open-market purchase
- Sep 3, 2024+$597KINBXChief Executive Officer Lappe Mark bought $596,763 worth of shares (40,000 units at $14.92)Form 4Open-market purchase
- Aug 21, 2024+$518KINBXChief Executive Officer Lappe Mark bought $518,282 worth of shares (40,000 units at $12.96)Form 4Open-market purchase
- May 30, 2024INBXLappe Mark returned $91,369,620 worth of shares to the company (3,045,654 units at $30.00)Form 4Sale back to the company
- Feb 28, 2023-$1,501INBXSEC Form 4: Lappe Mark sold $1,501 worth of shares (60 units at $25.02)Form 4Open-market sale10b5-1 plan
- Jan 24, 2023-$661KINBXSEC Form 4: Lappe Mark sold $660,842 worth of shares (26,000 units at $25.42)Form 4Open-market sale10b5-1 plan
- Jan 3, 2023INBXSEC Form 4 filed by Lappe MarkForm 4Grant or award
- Dec 19, 2022-$664KINBXSEC Form 4: Lappe Mark sold $664,443 worth of shares (26,000 units at $25.56)Form 4Open-market sale10b5-1 plan
- Nov 17, 2022-$725KINBXSEC Form 4: Lappe Mark sold $724,910 worth of shares (26,000 units at $27.88)Form 4Open-market sale10b5-1 plan
- Oct 17, 2022-$769KINBXSEC Form 4: Lappe Mark sold $769,443 worth of shares (26,000 units at $29.59)Form 4Open-market sale10b5-1 plan
- Jan 15, 2021INBXSEC Form 4: Mark Lappe gifted 500,000 units of Common Stock and received a gift of 500,000 units of Common StockForm 4Grant or awardGift
Compare Mark Lappe with
- Mark Lappe vs Jon Faiz Kayyem1 shared
- Mark Lappe vs Douglas Forsyth1 shared
- Mark Lappe vs Kristiina MD Vuori1 shared
- Mark Lappe vs Kimberly Manhard1 shared
- Mark Lappe vs David Matly1 shared
- Mark Lappe vs Kelly Deck1 shared
Other insiders at the same companies
- Jon Faiz KayyemINBX
- Douglas ForsythINBX
- Kristiina MD VuoriINBX
- Kimberly ManhardINBX
- David MatlyINBX
- Viking Global Investors LPINBX
- Kelly DeckINBX
Questions about Mark Lappe
- What is Mark Lappe's role at Inhibrx Biosciences, Inc.?
- Mark Lappe reports to the SEC as chief Executive Officer and director at Inhibrx Biosciences, Inc. (INBX), according to the latest filing on September 28, 2026.
- Has Mark Lappe bought or sold stock recently?
- The most recent open-market purchase was on September 28, 2026: bought 10,000 shares of Inhibrx Biosciences, Inc. (INBX) for $999K at an average of $99.88. The most recent open-market sale was on February 28, 2023: sold 60 shares of Inhibrx, Inc. (INBX) for $1,501 at an average of $25.02.
- How do I get alerts when Mark Lappe files?
- Follow Mark Lappe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Lappe filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Mark Lappe (SEC CIK 0001366074). Totals count each trade once, skipping amendments whose original is on file, from Jan 19, 2021 on. View on SEC EDGAR